) Safety and Immunogenicity of mRNA-1018, a Candidate Vaccine for the Prevention of H5N1 Pandemic Influenza, in Healthy Adults ... We present findings from a phase 1/2 trial that assessed the reactogenicity, safety and immunogenicity of mRNA-1018 among.